ARCHIVES

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Katterhagen, Nelson Reelected ACCC Leaders

February 4, 1977

DePinho’s Letter to the AAUP

May 30, 2014

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

NCI Increases R01 Grant Payline From 12th to 15th Percentile.

June 29, 2007

After a “humble” start at NCI, von Eschenbach set unachievable goal.

September 30, 2005

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007